Office Depot, Inc. (NASDAQ:ODP) said its sales for the third quarter rose 55% from a year earlier, as it continued to benefit from the merger with OfficeMax. The results beat analyst expectations, leading the company to raise its outlook for the year. The company now expects operating income of $255 million to $265 million, up from its previous outlook of about $200 million. Its preliminary estimate for next year is about $475 million. Office Depot, Inc. (NASDAQ:ODP) belongs to Services sector. Its net profit margin is -2.20% and weekly performance is 20.34%. On last trading day company shares ended up $6.33. Office Depot, Inc. (NASDAQ:ODP) distance from 50-day simple moving average (SMA50) is 21.19%. On Oct 27, McDermott International Inc. (NYSE:MDR) announced that it plans to issue a press release regarding its financial results for the third quarter 2014 on Wednesday, November 5, 2014, after the close of trading on the New York Stock Exchange. McDermott International Inc. (NYSE:MDR) shares fell -4.10% in last trading session and ended the day at $3.74. MDR Gross Margin is -4.50% and its return on assets is -14.20%. McDermott International Inc. (NYSE:MDR) quarterly performance is -49.46%. On Oct. 23, Maxwell Technologies, Inc. (NASDAQ:MXWL) announced a joint development agreement with Corning Incorporated (NYSE: GLW) with the goal of advancing the state of capacitive energy storage technology by addressing the challenges frequently cited by ultracapacitor customers, including energy density, lifetime, operating environment, form factor and cost. On 04 November, Maxwell Technologies, Inc. (NASDAQ:MXWL) shares fell -2.17% and was closed at $11.25. MXWL EPS growth in last 5 year was 18.20%. Maxwell Technologies, Inc. (NASDAQ:MXWL) year to date (YTD) performance is 44.79%. On Oct 28, Xylem Inc. (NYSE:XYL), announced third quarter 2014 net income of $106 million, or $0.58 per share. Excluding the gain on the sale of a business, impact of restructuring and realignment costs and other special charges, adjusted net income was $97 million or $0.53 per share, an increase of 4 cents or 8 percent from the comparable period in 2013. Third quarter revenue was $963 million, up 1 percent organically, reflecting strength in the U.S. and emerging markets, which was partially offset by weaker market conditions in Europe. Xylem Inc. (NYSE:XYL) ended the last trading day at $35.94. Company weekly volatility is calculated as 2.09% and price to cash ratio as 12.36. Xylem Inc. (NYSE:XYL) showed a weekly performance of -1.48%. On Oct 20, The Board of Directors of Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced that Lloyd H. Dean has tendered his resignation as a member of the Board, effective November 1, 2014. Mr. Dean has served as a director of the Company since 2010 and served as Chairman of the Company’s Board of Directors from April 2011 until June 2013. Cytori Therapeutics, Inc. (NASDAQ:CYTX) shares fell -2.83% in last trading session and ended the day at $0.48. CYTX Gross Margin is 64.00% and its return on assets is -96.80%. Cytori Therapeutics, Inc. (NASDAQ:CYTX) quarterly performance is -73.18%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
